References
1. Pokrovsky N.S., Vodyakova M.A., Merkulov V.A., Melnikova E.V. Specific aspects and key parameters of validation for methods of phenotyping of cell lines included in cell therapy products. Immunologiya. 2024; 45 (3): 353–54. DOI: https://doi.org/10.33029/1816-2134-2024-45-3-353-354 (in Russian)
2. Trusov G.A., Chaplenko A.A., Semenova I.S., Melnikova E.V., Olefir Yu.V. Use of Flow Cytometry for Quality Evaluation of Biomedical Cell Products. Biopreparaty Profilaktika, diagnostika, lechenie. 2018; 18 (1): 16–24. DOI: https://doi.org/10.30895/2221-996X-2018-18-1-16-24 (in Russian)
3. O’Hara D.M., Xu Y., Liang Z., Reddy M.P., Wu D.Y., Litwin V. Recommendations for the validation of flow cytometric testing during drug development: II assays. J Immunol Methods. 2011; 363 (2): 120–34. DOI: https://doi.org/10.1016/j.jim.2010.09.036
4. Kim H., Shin S., Hwang S.H., Kim M., Cho Younguk, Jang S. Validation of High-sensitivity Flow Cytometry for Reliable Immune Cell Analysis in Real-world Laboratory Settings. Ann Lab Med. 2023; 43 (6): 620–4. DOI: https://doi.org/10.3343/alm.2023.43.6.620
5. Viganò M., Budelli S., Lavazza C., Montemurro T., Montelatici E., De Cesare S., Lazzari L., Orlandi A.R., Lunghi G., Giordano R. Tips and Tricks for Validation of Quality Control Analytical Methods in Good Manufacturing Practice Mesenchymal Stromal Cell Production. Stem Cells Int. 2018; 2018: 1–16. DOI: https://doi.org/10.1155/2018/3038565
6. Selliah N., Nash V., Eck S., Green C., Oldaker T., Stewart J., Vitaliti A., Litwin V. Flow Cytometry Method Validation Protocols. Curr Protoc Cytom. 2023; 3 (8): e868. DOI: https://doi.org/10.1002/cpz1.868
7. European Medicines Agency (EMA). ICH Q14 Guideline on analytical procedure development. 2023. URL: https://www.ema.europa.eu/en/documents/scientific-guideline/ich-q14-guideline-analytical-procedure-development-step-5_en.pdf
8. European Medicines Agency (EMA). ICH Topic Q2 (R2) Validation of Analytical Procedures: Text and Methodology. 2023. URL: https://www.ema.europa.eu/en/documents/scientific-guideline/ich-q2r2-guideline-validation-analytical-procedures-step-5-revision-1_en.pdf
9. CLSI. H62. Validation of Assays Performed by Flow Cytometry. 1st ed. 2021. 234 p. ISBN: 978-1-68440-128-4
10. The Ministry of Health of the Russian Federation. The State Pharmacopoeia of the Russian Federation XV edition. OFS.1.1.0012 «Validation of analytical techniques». 2023. URL: https://pharmacopoeia.regmed.ru/pharmacopoeia/izdanie-15/1/1-1/validatsiya-analiticheskikh-metodik/ (in Russian)
11. Burel J.G., Qian Y., Lindestam Arlehamn C., Weiskopf D., Zapardiel-Gonzalo J., Taplitz R., Gilman R.H., Saito M., De Silva A.D., Vijayanand P., Scheuermann R.H., Sette A., Peters B. An Integrated Workflow To Assess Technical and Biological Variability of Cell Population Frequencies in Human Peripheral Blood by Flow Cytometry. J Immunol. 2017; 198 (4): 1748–58. DOI: 10.4049/jimmunol.1601750
12. Dorn-Beineke A., Sack U. Quality control and validation in flow cytometry. LaboratoriumsMedizin. 2016; 40 (s1): 000010151520160016. DOI: https://doi.org/10.1515/labmed-2016-0016
13. Lee J.W., Devanarayan V., Barrett Y.C., Weiner R., Allinson J., Fountain S., Keller S., Weinryb I., Green M., Duan L., Rogers J.A., Millham R., O’Brien P.J., Sailstad J., Khan M., Ray C., Wagner J.A. Fit-for-Purpose Method Development and Validation for Successful Biomarker Measurement. Pharm Res. 2006; 23 (2): 312–28. DOI: https://doi.org/10.1007/s11095-005-9045-3
14. Tangri S., Vall H., Kaplan D., Hoffman B., Purvis N., Porwit A., Hunsberger B., Shankey T.V. Validation of cell-based fluorescence assays: Practice guidelines from the ICSH and ICCS – part III – analytical issues Cytometry B Clin Cytom. 2013; 84 (5): 291–308. DOI: https://doi.org/10.1002/cyto.b.21106
15. Wood B., Jevremovic D., Béné M.C., Yan M., Jacobs P., Litwin V. Validation of cell-based fluorescence assays: Practice guidelines from the ICSH and ICCS – part V – assay performance criteria. Cytometry B Clin Cytom. 2013; 84 (5): 315–23. DOI: https://doi.org/10.1002/cyto.b.21108
16. Lambert C., Yanikkaya D. G., Keller T., Preijers F., Psarra K., Schiemann M., Özçürümez M., Sack U. Flow Cytometric Analyses of Lymphocyte Markers in Immune Oncology: A Comprehensive Guidance for Validation Practice According to Laws and Standards. Front Immunol. 2020; 11: 2169. DOI: https://doi.org/10.3389/fimmu.2020.02169
17. Mfarrej B., Gaude J., Couquiaud J., Calmels B., Chabannon C., Lemarie C. Validation of a flow cytometry-based method to quantify viable lymphocyte subtypes in fresh and cryopreserved hematopoietic cellular products. Cytotherapy. 2021; 23 (1): 77–87. DOI: https://doi.org/10.1016/j.jcyt.2020.06.005
18. Davis B.H., Wood B., Oldaker T., Barnett D. Validation of cell-based fluorescence assays: Practice guidelines from the ICSH and ICCS – part I – rationale and aims. Cytometry B Clin Cytom. 2013; 84 (5): 282–5. DOI: https://doi.org/10.1002/cyto.b.21104
19. Davis B.H., Dasgupta A., Kussick S., Han J.Y., Estrellado A. Validation of cell-based fluorescence assays: practice guidelines from the ICSH and ICCS – part II – preanalytical issues. Cytometry B Clin Cytom. 2013; 84 (5): 286–90. DOI: https://doi.org/10.1002/cyto.b.21105
20. Barnett D., Louzao R., Gambell P., De J., Oldaker T., Hanson C.A. Validation of cell-based fluorescence assays: Practice guidelines from the ICSH and ICCS – part IV – postanalytic considerations. Cytometry B Clin Cytom. 2013; 84 (5): 309–14. DOI: https://doi.org/10.1002/cyto.b.21107
21. Collins L.M., Dziak J.J., Li R. Design of experiments with multiple independent variables: A resource management perspective on complete and reduced factorial designs. Psychol Methods. 2009; 14 (3): 202–24. DOI: https://doi.org/10.1037/a0015826